Michael S. Cuffe
EVP and Chief Clinical Officer · HCA Healthcare, Inc.
- 2025
- Feb 12, 2026
- 4
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Michael S. Cuffe files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Samuel N. Hazen - $21.48M in HCA purchases and sales in the last 12 months
- Jennifer Berres - $4.13M in HCA purchases and sales in the last 12 months
- Michael R. McAlevey - $2.75M in HCA purchases and sales in the last 12 months
- Christopher F. Wyatt - $2.02M in HCA purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Michael S. Cuffe?
Michael S. Cuffe is a corporate insider, tracked as EVP and Chief Clinical Officer of HCA Healthcare, Inc. (HCA). InsiderAlpha holds 4 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Michael S. Cuffe last file a Form 4?
The most recent primary Form 4 on record is dated 12 February 2026, one of 4 filings going back to 2025.
Has Michael S. Cuffe been buying or selling stock?
Recorded transactions: 0 open-market purchases and 2 open-market sales ($2.35M) across all tracked filings.
